Background: Most chemotherapeutic drugs are known to cause nephrotoxicity. Therefore, new strategies have been considered to prevent chemotherapy-induced nephrotoxicity. It is of note that (NS), or its isolated compound Thymoquinone (TQ), has a potential role in combating chemotherapy-induced nephrotoxicity.
Aim: To analyze and report the outcome of experimental animal studies on the protective effects of NS/TQ on chemotherapy-associated kidney complications.
Design: Standard systematic review and narrative synthesis.
Data Sources: MEDLINE, EMBASE databases were searched for relevant articles published up to March 2017. Additionally, a manual search was performed. Criteria for a study's inclusion were: conducted in animals, systematic reviews and meta-analysis, containing data on nephroprotective effects of NS/TQ compared to a placebo or other substance. All strains and genders were included.
Results: The database search yielded 71 studies, of which 12 (cisplatin-induced nephrotoxicity 8; methotrexate-induced nephrotoxicity 1; doxorubicin-induced nephrotoxicity 2; ifosfamide-induced nephrotoxicity 1) were included in this review.
Conclusions: Experimental animal studies showed the protective effect of NS, or TQ, on chemotherapy-induced nephrotoxicity. These effects are caused by decreasing lipid peroxidation and increasing activity of antioxidant enzymes in renal tissue of chemotherapy-treated animals.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490604 | PMC |
| http://dx.doi.org/10.3390/nu9060625 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Remote organ cancer induces kidney injury, inflammation, and fibrosis and adversely alters renal function.
Am J Physiol Renal Physiol
December 2024
Department of Medicine, Division of Medical Oncology and Hematology, University of Louisville School of Medicine.
Approximately 30% of cancer patients experience kidney complications, which hinder optimal cancer management, imposing a burden on patients' quality of life and the healthcare system. The etiology of kidney complications in cancer patients is often attributed to oncological therapies. However, the direct impact of cancer on kidney health is underestimated.
View Article and Find Full Text PDFOmega-3 polyunsaturated fatty acids protect against cisplatin-induced nephrotoxicity by activating the Nrf2 signaling pathway.
Int J Biol Macromol
December 2024
The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, China. Electronic address:
Nephrotoxicity is a prevalent side effect observed in patients undergoing chemotherapy. The pathogenesis of chemotherapy-induced nephrotoxicity involves various factors such as oxidative stress, DNA damage, inflammation, and apoptosis. Omega-3 polyunsaturated fatty acids (ω-3 PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), possess anti-inflammatory and antioxidant properties.
View Article and Find Full Text PDFApproximately 30% of cancer patients experience kidney complications, which hinder optimal cancer management, imposing a burden on patients' quality of life and the healthcare system. The etiology of kidney complications in cancer patients is often attributed to nephrotoxic oncological therapies. However, the direct impact of cancer on kidney health is underestimated, as most nephrotoxic oncological therapies have been studied in animal models that do not have cancer.
View Article and Find Full Text PDFChemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches.
Front Nephrol
August 2024
Hematology Department, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.
Article Synopsis
- Conventional chemotherapy is still the main treatment for various cancers, despite advancements in the field, but it often leads to acute kidney injury (AKI), a serious side effect.
- Nephrotoxic effects are commonly linked to platinum-based drugs, but other chemotherapy agents, including antimetabolites and alkylating agents, can also cause kidney damage.
- The article reviews the causes, risks, and management strategies for AKI during chemotherapy, and discusses prevention methods, though avoiding kidney injury remains difficult due to multiple contributing factors.
Unveiling the therapeutic potential of Taxifolin in Cancer: From molecular mechanisms to immune modulation and synergistic combinations.
Phytomedicine
October 2024
Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates; College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates. Electronic address:
Article Synopsis
- - Taxifolin (TAX), a natural flavonoid found in medicinal plants, shows potential in cancer therapy by inhibiting tumor growth and enhancing the effectiveness of traditional chemotherapy through various biological mechanisms.
- - The review analyzes TAX’s antitumor mechanisms, its synergistic effects with chemotherapeutic agents, and its ability to protect cells from chemotherapy-related toxicities, while also exploring its safety and pharmacokinetic challenges.
- - Research indicates that TAX can block tumor cell proliferation and invasion by targeting specific pathways, and it also has a beneficial role in improving immune responses against tumors, potentially enhancing the effectiveness of immune therapies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!